Modern Methods of Drug Design and Development (Methods in Enzymology)

個数：

Modern Methods of Drug Design and Development (Methods in Enzymology)

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    【重要ご説明事項】
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版／ページ数 598 p.
  • 言語 ENG
  • 商品コード 9780443158711
  • DDC分類 615.19

Full Description

Modern Methods of Drug Design and Development, a volume in the Methods in Enzymology series highlights new advances in the field with this new volume presenting interesting chapters on a variety of topics, including Recombinant protein purification for structural and kinetic studies, Steady-state kinetic analysis of reversible enzyme inhibitors, Steady-State Enzyme Kinetics, Analysis of enzyme kinetic data using ICEKAT, NMR techniques in drug discovery, Dynamic simulations and pre-steady state kinetics to guide drug discovery, Design and assay of substrate-product analogues for racemases and epimerases, Sensitive high throughput methods to screen for P450 inhibition: A- MI complex forming drugs, and more.

Other chapters cover Sensitive high throughput methods to screen for P450 inhibition: B-Heme loss causing drugs, Discovery and development of inhibitors of acetyltransferase Eis to combat Mycobacterium tuberculosis, Crystallographic fragment screening in academic cancer drug discovery, Fast fragment- and compound-screening pipeline at the Swiss Light Source, Chemical biology, enzymology and drug discovery, PROTACs, Proximity-Induced Pharmacology (PROTACs), and much more.

Contents

1. Recombinant protein purification for structural and kinetic studies
Matthew Lloyd, Otsile Mojanaga and K Ravi Acharya
2. Steady-state kinetic analysis of reversible enzyme inhibitors
Matthew Lloyd
3. Steady-State Enzyme Kinetics
Bharath Srinivasan
4. Analysis of enzyme kinetic data using ICEKAT
Brian C. Smith
5. NMR techniques in drug discovery
Tim Woodman
6. Dynamic simulations and pre-steady state kinetics to guide drug discovery
Ken Johnson
7. Design and assay of substrate-product analogues for racemases and epimerases
Stephen L. Bearne
8. Sensitive high throughput methods to screen for P450 inhibition: A- MI complex forming drugs
Rheem Totah
9. Sensitive high throughput methods to screen for P450 inhibition: B-Heme loss causing drugs
Rheem Totah
10. Discovery and development of inhibitors of acetyltransferase Eis to combat Mycobacterium tuberculosis
Sylvie Garneau-Tsodikova and Oleg Tsodikov
11. Crystallographic fragment screening in academic cancer drug discovery
Jane Endicott, Martin Noble and Mathew Martin
12. Fast fragment- and compound-screening pipeline at the Swiss Light Source
Justyna A. Wojdyla, May E. Sharpe and Guenter Fritz
13. Chemical biology, enzymology and drug discovery
Kevin Dalby
14. PROTACs
Matthias Baud
15. Proximity-Induced Pharmacology (PROTACs)
Matthieu Schapira
16. Chemo-enzymatic Labelling with asparaginyl endopeptidase (AEP)
Louis Luk
17. Development of 5-Aminolevulinic Acid Prodrugs for Photodynamic Therapy and Photodiagnosis
Ian Eggleston
18. Systems biology and single cell approaches
Udo Opperman